18f fp-r01-mg-f2
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT02683824)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f fp-r01-mg-f2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03183570 | Early Phase 1 (Phase 1) | Jun 25, 2017 | Pliant Therapeutics, Stanford University |
| NCT02683824 | N/A | Jan 1, 2016 | National Cancer Institute (NCI), Stanford University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Stanford University | Academic/Hospital | 2 | 2 | 2 | 2016 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2016 |
| Pliant Therapeutics | For profit | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1